Anika Therapeutics, Inc. (ANIK) Reports Improved Q4 EPS of $0.21

Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q4 EPS of $0.21, versus $0.10 reported last year. Revenue for the quarter came in at $18.4 million, versus $14.7 million reported last year.

For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Citi raises Huya price target to $4.60 from $4.40
• Home Depot CEO takes medical leave 6 days before Q2 earnings